(Q48009892)
Statements
Activation of tumor-specific CD4(+) T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy (English)
Samudra K Dissanayake
James A Thompson
Virginia K Clements
Peter W Chen
Suzanne Ostrand-Rosenberg
1 March 2004